Search Results - Lomovskaya, Maria I

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Crystal structures of a llama VHH antibody BCD090-M2 targeting human ErbB3 receptor [version 2; peer review: 2 approved]

    Crystal structures of a llama VHH antibody BCD090-M2 targeting human ErbB3 receptor [version 2; peer review: 2 approved] by Eliseev, Igor E, Yudenko, Anna N, Vysochinskaya, Vera V, Svirina, Anna A, Evstratyeva, Anna V, Drozhzhachih, Maria S, Krendeleva, Elena A, Vladimirova, Anna K, Nemankin, Timofey A, Ekimova, Viktoria M, Ulitin, Andrey B, Lomovskaya, Maria I, Yakovlev, Pavel A, Bukatin, Anton S, Knyazev, Nickolay A, Moiseenko, Fedor V, Chakchir, Oleg B

    Published in F1000 research
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Crystal structures of a llama VHH antibody BCD090-M2 targeting human ErbB3 receptor [version 1; peer review: 1 approved, 1 approved with reservations]

    Crystal structures of a llama VHH antibody BCD090-M2 targeting human ErbB3 receptor [version 1; peer review: 1 approved, 1 approved with reservations] by Eliseev, Igor E, Yudenko, Anna N, Vysochinskaya, Vera V, Svirina, Anna A, Evstratyeva, Anna V, Drozhzhachih, Maria S, Krendeleva, Elena A, Vladimirova, Anna K, Nemankin, Timofey A, Ekimova, Viktoria M, Ulitin, Andrey B, Lomovskaya, Maria I, Yakovlev, Pavel A, Bukatin, Anton S, Knyazev, Nickolay A, Moiseenko, Fedor V, Chakchir, Oleg B

    Published in F1000 research
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Effect and Safety of Meropenem–Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections: The TANGO II Randomized Clinical Trial

    Effect and Safety of Meropenem–Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections: The TANGO II Randomized Clinical Trial... by Wunderink, Richard G., Giamarellos-Bourboulis, Evangelos J., Rahav, Galia, Mathers, Amy J., Bassetti, Matteo, Vazquez, Jose, Cornely, Oliver A., Solomkin, Joseph, Bhowmick, Tanaya, Bishara, Jihad, Daikos, George L., Felton, Tim, Furst, Maria Jose Lopez, Kwak, Eun Jeong, Menichetti, Francesco, Oren, Ilana, Alexander, Elizabeth L., Griffith, David, Lomovskaya, Olga, Loutit, Jeffery, Zhang, Shu, Dudley, Michael N., Kaye, Keith S.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Quinazolinone fungal efflux pump inhibitors. Part 3: ( N-methyl)piperazine variants and pharmacokinetic optimization

    Quinazolinone fungal efflux pump inhibitors. Part 3: ( N-methyl)piperazine variants and pharmacokinetic optimization by Watkins, William J., Chong, Lee, Cho, Aesop, Hilgenkamp, Ramona, Ludwikow, Maria, Garizi, Negar, Iqbal, Nadeem, Barnard, John, Singh, Rajeshwar, Madsen, Deidre, Lolans, Karen, Lomovskaya, Olga, Oza, Uma, Kumaraswamy, Padmapriya, Blecken, Andrea, Bai, Shuang, Loury, David J., Griffith, David C., Dudley, Michael N.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Quinazolinone fungal efflux pump inhibitors. Part 2: In vitro structure–activity relationships of (N-methyl-piperazinyl)-containing derivatives

    Quinazolinone fungal efflux pump inhibitors. Part 2: In vitro structure–activity relationships of (N-methyl-piperazinyl)-containing derivatives by Watkins, William J., Lemoine, Rémy C., Chong, Lee, Cho, Aesop, Renau, Thomas E., Kuo, Bonnie, Wong, Vickie, Ludwikow, Maria, Garizi, Negar, Iqbal, Nadeem, Barnard, John, Jankowska, Renata, Singh, Rajeshwar, Madsen, Deidre, Lolans, Karen, Lomovskaya, Olga, Oza, Uma, Dudley, Michael N.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: